Skip to main content
. Author manuscript; available in PMC: 2013 Aug 28.
Published in final edited form as: Organometallics. 2012 Jul 25;31(16):5772–5781. doi: 10.1021/om3006239

Fig. 3.

Fig. 3

Electrophoresis mobility shift assays for cisplatin, ligand 1 and compounds 2 and 3 (see Experimental for details). DNA refers to untreated plasmid pBR322. a, b, and c correspond to metal/DNA ratios of 0.25, 0.5, and 1.0 respectively.